Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
High density lipoprotein measurement
|
1440 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.800 | 1.000 | 22 | 2008 | 2019 | |||||
Age related macular degeneration
|
663 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.860 | 1.000 | 8 | 2010 | 2018 | |||||
Serum HDL cholesterol measurement
|
679 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 8 | 2008 | 2013 | |||||
Serum total cholesterol measurement
|
1243 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.800 | 1.000 | 8 | 2010 | 2019 | |||||
Triglycerides measurement
|
1418 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.800 | 1.000 | 6 | 2009 | 2018 | |||||
Low density lipoprotein cholesterol measurement
|
1142 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.800 | 1.000 | 5 | 2010 | 2019 | |||||
Metabolic Syndrome X
|
591 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.830 | 1.000 | 5 | 2010 | 2018 | |||||
Polypoidal choroidal vasculopathy
|
67 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.040 | 1.000 | 4 | 2013 | 2018 | |||||
Serum LDL cholesterol measurement
|
555 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 3 | 2010 | 2013 | |||||
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
526 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
AIDS, PROGRESSION TO
|
526 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
Aortic Aneurysm, Abdominal
|
90 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Cardiovascular Diseases
|
711 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.010 | 1 | 2015 | 2015 | ||||||
Coronary heart disease
|
1178 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2011 | 2011 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.010 | 1 | 2015 | 2015 | ||||||
Dyslipidemias
|
184 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Exudative age-related macular degeneration
|
109 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
exudative macular degeneration
|
69 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
Glycogen storage disease type II
|
269 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
HIV-1, RESISTANCE TO
|
526 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
527 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||
Hypertensive disease
|
1085 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Lipids measurement
|
53 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||
Myocardial Infarction
|
680 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Obesity
|
1111 | 0.732 | 0.280 | 16 | 56959412 | upstream gene variant | C/A | snv | 0.31 | 0.010 | 1.000 | 1 | 2015 | 2015 |